On Tuesday, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares inclined 2.80%, and closed at $0.550, soon after AEterna Zentaris (AEZS), declared that it has agreed to transfer its discovery library of roughly 100,000 unique compounds to the South Carolina Center for Therapeutic Discovery & Development (the Center) following a just concluded Material Transfer Contract. This Contract represents the starting of a long-term relationship between the Corporation and the Center, which is part of The Medical University of South Carolina (MUSC), that will result in the continued use of the library for the discovery of drug development candidates for the Corporation in the areas of oncology, neurology, endocrinology and women’s health. The Center may make the library accessible to all investigators in the University of South Carolina system without restriction on its use and will own any therapeutic compounds discovered outside the Corporation’s areas of therapeutic interest.
The Center has agreed to conduct screening and pre-clinical activities with respect to the library with a view toward submitting to the Corporation at least one development candidate in its areas of therapeutic interest per year during a ten-year period startning in 2018. The Corporation will receive the right of first refusal to license the development candidates.
Aeterna Zentaris Inc., a specialty biopharmaceutical corporation, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The corporation’s product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
Diamond Offshore Drilling Inc (NYSE:DO)’s shares raised 2.79%, and settled at $29.80, during the last trading session on Tuesday, as Loews Corporation is a diversified corporation with three publicly-traded auxiliaries: CNA Financial Corporation (CNA), Diamond Offshore Drilling, Inc. (DO) and Boardwalk Pipeline Partners, LP (BWP); and one wholly owned partner, Loews Hotels & Resorts.
Loews Corporation (NYSE:L) will report first quarter 2015 financial results on Monday, May 4, 2015. A conference call for analysts and investors will start at 11:00 a.m. EDT and will be hosted by the Corporation’s chief executive officer, James S. Tisch, and chief financial officer, David B. Edelson.
Another news, Diamond Offshore Drilling, Inc. (NYSE: DO), declared that it will issue a press release and host a conference call and webcast related to its first quarter 2015 operating results on Monday, May 4, 2015. The conference call and webcast will start at 7:30 a.m. CDT and will comprise a talk about by administration regarding the Corporation’s results of operation.
Diamond Offshore Drilling, Inc. provides contract drilling services to the energy industry worldwide. The corporation provides services in floater market, such as ultra-deepwater, deepwater, and mid-water; and non-floater or jack-up market. It operates a fleet of 38 offshore drilling rigs, which comprise 27 semisubmersibles, counting 1 under construction; 6 jack-ups; and 5 dynamically positioned drillships, counting 1 under construction. Diamond Offshore Drilling, Inc. serves independent oil and gas companies, and government-owned oil companies.
At the end of Tuesday’s trade, Quiksilver, Inc (NYSE:ZQK)’s shares picked up 2.79%, and closed at $1.84, formerly on March 27, Quiksilver, (ZQK), declared that Pierre Agnes, President of Quiksilver, Inc., has been promoted to Chief Executive Officer and added to the Board of Directors; he succeeds Andy Mooney who is no longer with the corporation. In addition, Greg Healy, Quiksilver’s APAC Region President, has been promoted to President of Quiksilver, Inc., and Bob McKnight has been designated Chairman.
Bob McKnight, Founder and Chairman of Quiksilver, Inc., said, “On behalf of the board, I want to thank Andy Mooney for his leadership in driving the organizational changes that were essential to restoring our product design leadership and globalizing many of our key functions. This work provides the foundation for the next phase of Quiksilver’s progress.
Quiksilver, Inc. designs, develops, and distributes branded apparel, footwear, accessories, and related products primarily for men, women, and children. The corporation provides its products for various activities, counting casual and outdoor lifestyle associated with surfing, skateboarding, snowboarding, BMX and motocross, rally car, and other activities.
ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), ended its Tuesday’s trading session with 2.75% gained, and closed at $32.84, ACADIA Pharmaceuticals (ACAD), declared that it will present at the 14th Annual Needham Healthcare Conference on Tuesday, April 14, 2015, at 9:20 a.m. Eastern Time in New York City.
ACADIA Pharmaceuticals Inc., a biopharmaceutical corporation, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which accomplished the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis; is in Phase II study for Alzheimer’s disease psychosis; and has accomplished Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in partnershipwith Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
